Song H, Zhang M, Guo C, Guo X, Ma Y, Ma Y
Front Cell Dev Biol. 2025; 13:1523958.
PMID: 39968176
PMC: 11833226.
DOI: 10.3389/fcell.2025.1523958.
Lim M, Kim T, Kim H, Jang B, Myung J, Kim H
Cell Mol Immunol. 2024; 22(1):97-110.
PMID: 39653767
PMC: 11685411.
DOI: 10.1038/s41423-024-01242-x.
Rina A, Maffeo D, Minnai F, Esposito M, Palmieri M, Serio V
Cancers (Basel). 2024; 16(16).
PMID: 39199653
PMC: 11352260.
DOI: 10.3390/cancers16162882.
Kumar M, Patil K, Maity P, Chatterjee J, Singh T, Joshi G
RSC Med Chem. 2024; 15(7):2322-2339.
PMID: 39026650
PMC: 11253857.
DOI: 10.1039/d4md00237g.
Hu Q, Wang M, Wang J, Tao Y, Niu T
Oncol Res. 2024; 32(4):753-768.
PMID: 38560563
PMC: 10972724.
DOI: 10.32604/or.2023.043647.
Personalized Medicine in Medullary Thyroid Carcinoma: A Broad Review of Emerging Treatments.
Martins R, Jesus T, Cardoso L, Soares P, Vinagre J
J Pers Med. 2023; 13(7).
PMID: 37511745
PMC: 10381735.
DOI: 10.3390/jpm13071132.
Utilization of Supervised Machine Learning to Understand Kinase Inhibitor Toxophore Profiles.
Bieberich A, Asquith C
Int J Mol Sci. 2023; 24(6).
PMID: 36982163
PMC: 10049021.
DOI: 10.3390/ijms24065088.
Novel Erlotinib-Chalcone Hybrids Diminish Resistance in Head and Neck Cancer by Inducing Multiple Cell Death Mechanisms.
Muranyi J, Duro C, Gurbi B, Mora I, Varga A, Nemeth K
Int J Mol Sci. 2023; 24(4).
PMID: 36834866
PMC: 9964293.
DOI: 10.3390/ijms24043456.
Discovery of a Novel Potent Antitumor Molecule, P19G1, by Erlotinib Derivative Libraries Synthesized by Modular Click-Chemistry.
Cui Q, Song P, Ma T, Wang Z, Lu X, Shi Y
Technol Cancer Res Treat. 2022; 21:15330338221109649.
PMID: 36303409
PMC: 9619925.
DOI: 10.1177/15330338221109649.
Resistor: An algorithm for predicting resistance mutations via Pareto optimization over multistate protein design and mutational signatures.
Guerin N, Feichtner A, Stefan E, Kaserer T, Donald B
Cell Syst. 2022; 13(10):830-843.e3.
PMID: 36265469
PMC: 9589925.
DOI: 10.1016/j.cels.2022.09.003.
Benzimidazole-linked pyrazolo[1,5-a]pyrimidine conjugates: synthesis and detail evaluation as potential anticancer agents.
Bagul C, Rao G, Veena I, Kulkarni R, Tamboli J, Akunuri R
Mol Divers. 2022; 27(3):1185-1202.
PMID: 36114912
DOI: 10.1007/s11030-022-10481-x.
Discovery of BLU-945, a Reversible, Potent, and Wild-Type-Sparing Next-Generation EGFR Mutant Inhibitor for Treatment-Resistant Non-Small-Cell Lung Cancer.
Eno M, Brubaker J, Campbell J, De Savi C, Guzi T, Williams B
J Med Chem. 2022; 65(14):9662-9677.
PMID: 35838760
PMC: 9340769.
DOI: 10.1021/acs.jmedchem.2c00704.
Repurposing of anti-lung cancer drugs as multi-target inhibitors of SARS-CoV-2 proteins: An insight from molecular docking and MD-simulation study.
Reza R, Dutta T, Baildya N, Nath Ghosh N, Khan A, Das R
Microb Pathog. 2022; 169:105615.
PMID: 35690231
PMC: 9174081.
DOI: 10.1016/j.micpath.2022.105615.
Transition-metal and oxidant-free approach for the synthesis of diverse N-heterocycles by TMSCl activation of isocyanides.
Luo L, Li H, Liu J, Zhou Y, Dong L, Xiao Y
RSC Adv. 2022; 10(49):29257-29262.
PMID: 35521093
PMC: 9055958.
DOI: 10.1039/d0ra04636a.
Biological Characteristics and Clinical Significance of Soluble PD-1/PD-L1 and Exosomal PD-L1 in Cancer.
Niu M, Liu Y, Yi M, Jiao D, Wu K
Front Immunol. 2022; 13:827921.
PMID: 35386715
PMC: 8977417.
DOI: 10.3389/fimmu.2022.827921.
Design, synthesis and evaluation of 4,7-disubstituted 8-methoxyquinazoline derivatives as potential cytotoxic agents targeting β-catenin/TCF4 signaling pathway.
Neogi K, Murumkar P, Sharma P, Yadav P, Tewari M, Karunagaran D
Transl Oncol. 2022; 19:101395.
PMID: 35325837
PMC: 8938628.
DOI: 10.1016/j.tranon.2022.101395.
Optimization of Brigatinib as New Wild-Type Sparing Inhibitors of EGFR Mutants.
Li S, Zhang T, Zhu S, Lei C, Lai M, Peng L
ACS Med Chem Lett. 2022; 13(2):196-202.
PMID: 35178175
PMC: 8842099.
DOI: 10.1021/acsmedchemlett.1c00555.
Pharmacological inhibition of epidermal growth factor receptor attenuates intracranial aneurysm formation by modulating the phenotype of vascular smooth muscle cells.
Luo Y, Tang H, Zhang Z, Zhao R, Wang C, Hou W
CNS Neurosci Ther. 2021; 28(1):64-76.
PMID: 34729926
PMC: 8673708.
DOI: 10.1111/cns.13735.
Computational Prediction of Chemical Tools for Identification and Validation of Synthetic Lethal Interaction Networks.
Bhanumathy K, Abuhussein O, Vizeacoumar F, Freywald A, Vizeacoumar F, Phenix C
Methods Mol Biol. 2021; 2381:333-358.
PMID: 34590285
DOI: 10.1007/978-1-0716-1740-3_18.
Matrix-assisted laser desorption ionization - mass spectrometry imaging of erlotinib reveals a limited tumor tissue distribution in a non-small-cell lung cancer mouse xenograft model.
Kim T, Lee B, Kim Y, Sugihara Y, Rezeli M, Szasz A
Clin Transl Med. 2021; 11(7):e481.
PMID: 34323418
PMC: 8265169.
DOI: 10.1002/ctm2.481.
